Actinium Pharmaceuticals, Inc. (delaware) · AMEX:ATNM
David Matthew T received 250,000 Actinium Pharmaceuticals, Inc. (delaware) shares as an award (Form 4)
Traded Oct 14, 2026 · Filed Oct 16, 2026
On Oct 14, 2026, David Matthew T (Chief Financial Officer) received 250,000 Actinium Pharmaceuticals, Inc. (delaware) shares as an award, leaving 250,000 shares. Filed Oct 16, 2026 (Form 4).
- Awarded
- 250,000 shares
- Holding after
- 250,000 shares
- Trading plan
- No
- Role
- Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Oct 14, 2026 | Common Stock | Award | 250,000 | 250,000 | Direct |
Source
Download original · View original at SEC
Related
- Actinium Pharmaceuticals, Inc. (delaware)
- David Matthew T
- Actinium Pharmaceuticals, Inc. (delaware) shareholders
- Form 4 · Nicholson, C. David · Sep 4, 2026
- Form 4 · Almenoff June Sherie · Sep 4, 2026
- Form 4 · Shetty Ajit · Sep 4, 2026
- Form 4 · Seth Sandesh · Sep 4, 2026
- Form 4 · Steinhart Richard I · Sep 4, 2026